A Prospective Trial with Long Term Follow-up of Patients With Severe, Steroid-Resistant Ulcerative Colitis Who Received Induction Therapy With Cyclosporine and Were Maintained With Vedolizumab

Ciclosporin Therapy After Infliximab Failure in Hospitalized Patients With Acute Severe Colitis is Effective and Safe

(2019) Roni Weisshof et al.   Journal of Crohns & Colitis

ACG Clinical Guideline

(2019) David T. Rubin et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Early vedolizumab trough levels at induction in inflammatory bowel disease patients with treatment failure during maintenance

(2019) Claire Liefferinckx et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease

(2019) Luisa Guidi et al.   United European Gastroenterology Journal

Efficacy and safety of induction therapy with calcineurin inhibitors followed by vedolizumab maintenance in 71 patients with severe steroid-refractory ulcerative colitis

(2019) Jacob E. Ollech et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease

(2018) Britt Christensen et al.   Clinical Gastroenterology and Hepatology

Preventive therapy for tuberculosis in rheumatological patients undergoing therapy with biological drugs

(2018) Delia Goletti et al.   Expert Review of Anti-Infective Therapy

Vedolizumab as Induction and Maintenance for Inflammatory Bowel Disease: 12-month Effectiveness and Safety

(2018) Britt Christensen et al.   INFLAMMATORY BOWEL DISEASES

Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination with Vedolizumab in Patients With Refractory Ulcerative Colitis

(2018) Gauthier Pellet et al.   Clinical Gastroenterology and Hepatology

New Promising Combo Therapy in Inflammatory Bowel Diseases Refractory to Anti-TNF Agents: Cyclosporine Plus Vedolizumab

(2017) Kata Szántó et al.   Journal of Crohns & Colitis

Loss of Response to Anti-TNFs: Definition, Epidemiology and Management

(2016) Giulia Roda et al.   Clinical and Translational Gastroenterology

Loss of Infliximab Into Feces Is Associated With Lack of Response to Therapy in Patients With Severe Ulcerative Colitis

(2015) Johannan F. Brandse et al.   GASTROENTEROLOGY

Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis

(2013) Remo Panaccione et al.   GASTROENTEROLOGY

Rescue Therapy with Cyclosporine or Infliximab is not Associated with an Increased Risk for Postoperative Complications in Patients Hospitalized for Severe Steroid-refractory Ulcerative Colitis

(2013) Ryan Nelson et al.   INFLAMMATORY BOWEL DISEASES

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

(2013) Brian G. Feagan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial

(2012) David Laharie et al.   LANCET

Treatment of choice for acute severe steroid-refractory ulcerative colitis is cyclosporine

(2008) Simon Lichtiger   INFLAMMATORY BOWEL DISEASES